CA1021772A - 1-aminopropoxy-isoquinoline - Google Patents

1-aminopropoxy-isoquinoline

Info

Publication number
CA1021772A
CA1021772A CA210,857A CA210857A CA1021772A CA 1021772 A CA1021772 A CA 1021772A CA 210857 A CA210857 A CA 210857A CA 1021772 A CA1021772 A CA 1021772A
Authority
CA
Canada
Prior art keywords
aminopropoxy
isoquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA210,857A
Other languages
English (en)
Inventor
Erik Wiskott
Franz Troxler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1021772A publication Critical patent/CA1021772A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
CA210,857A 1973-10-08 1974-10-07 1-aminopropoxy-isoquinoline Expired CA1021772A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1430773A CH581113A5 (zh) 1973-10-08 1973-10-08

Publications (1)

Publication Number Publication Date
CA1021772A true CA1021772A (en) 1977-11-29

Family

ID=4399720

Family Applications (1)

Application Number Title Priority Date Filing Date
CA210,857A Expired CA1021772A (en) 1973-10-08 1974-10-07 1-aminopropoxy-isoquinoline

Country Status (21)

Country Link
JP (1) JPS5082078A (zh)
AT (1) ATA802974A (zh)
AU (2) AU498889B2 (zh)
BE (1) BE820789A (zh)
CA (1) CA1021772A (zh)
CH (1) CH581113A5 (zh)
DD (1) DD114605A5 (zh)
DE (1) DE2447756A1 (zh)
DK (1) DK135766B (zh)
ES (1) ES430759A1 (zh)
FI (1) FI286374A (zh)
FR (1) FR2247242B1 (zh)
GB (1) GB1474775A (zh)
HU (1) HU169126B (zh)
IL (1) IL45797A (zh)
NL (1) NL7413105A (zh)
NO (1) NO743534L (zh)
PH (1) PH11611A (zh)
SE (1) SE7412310L (zh)
SU (1) SU567403A3 (zh)
ZA (1) ZA746409B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI760704A (zh) * 1975-03-26 1976-09-27 Sandoz Ag
US4129565A (en) * 1975-07-11 1978-12-12 Nisshin Flour Milling Co., Ltd. Isocarbostyril derivatives
SE7804318L (sv) * 1977-05-02 1978-11-03 Merck & Co Inc Nya naftyridiner
EP0711804A3 (de) 1994-11-14 1999-09-22 Ciba SC Holding AG Kryptolichtschutzmittel
US6346536B1 (en) 1997-09-03 2002-02-12 Guilford Pharmaceuticals Inc. Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same
US6514983B1 (en) 1997-09-03 2003-02-04 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
US6426415B1 (en) 1997-09-03 2002-07-30 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity
US6635642B1 (en) 1997-09-03 2003-10-21 Guilford Pharmaceuticals Inc. PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
US6197785B1 (en) * 1997-09-03 2001-03-06 Guilford Pharmaceuticals Inc. Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
US6395749B1 (en) 1998-05-15 2002-05-28 Guilford Pharmaceuticals Inc. Carboxamide compounds, methods, and compositions for inhibiting PARP activity
US6387902B1 (en) 1998-12-31 2002-05-14 Guilford Pharmaceuticals, Inc. Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
AU2001264595A1 (en) 2000-05-19 2001-12-03 Guilford Pharmaceuticals Inc. Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
AU2001275085A1 (en) 2000-06-01 2001-12-11 Guilford Pharmaceuticals Inc. Methods, compounds and compositions for treating gout

Also Published As

Publication number Publication date
GB1474775A (en) 1977-05-25
ZA746409B (en) 1976-05-26
CH581113A5 (zh) 1976-10-29
ATA802974A (de) 1979-07-15
NO743534L (zh) 1975-05-05
NL7413105A (nl) 1975-04-10
DE2447756A1 (de) 1975-04-10
AU7408974A (en) 1976-04-15
IL45797A (en) 1978-04-30
DD114605A5 (zh) 1975-08-12
DK135766C (zh) 1977-11-21
PH11611A (en) 1978-04-12
ES430759A1 (es) 1977-04-16
AU7409074A (en) 1976-04-15
AU7413074A (en) 1976-04-15
SU567403A3 (ru) 1977-07-30
IL45797A0 (en) 1974-12-31
HU169126B (zh) 1976-09-28
DK514874A (zh) 1975-06-09
AU498889B2 (en) 1979-03-29
SE7412310L (zh) 1975-04-09
DK135766B (da) 1977-06-20
FR2247242B1 (zh) 1978-07-21
BE820789A (fr) 1975-04-07
FR2247242A1 (zh) 1975-05-09
JPS5082078A (zh) 1975-07-03
FI286374A (zh) 1975-04-09

Similar Documents

Publication Publication Date Title
AU474137B2 (en) Auto-refractometer
AU468964B2 (en) Melik
CA1012517A (en) Railbed
AU498889B2 (en) Piperidylene benzocycloheptathiophenes
CA1031258A (en) Para-influenza-3-virus
AU476397B2 (en) A-cycloalkylbenzyl lactamimides
AU6659874A (en) Alkylbenxyl lactamimides
AU472907B2 (en) Firecheck
CA1034593A (en) Amidinoureas
CA1015606A (en) Tyreroller
CA1003826A (en) Dibenzocycloheptenyl lactamimides
AU471241B2 (en) Benzothiazolylureas
AU492033B2 (en) D-homo-20-keto-pregnanes
AU492247B2 (en) Ethenoanthracenes
AU478880B2 (en) 3-isoxazolidinones
CA996384A (en) Goniolens
AU479426B2 (en) Carbothiolates
AU481998B2 (en) Benzenedisulfonamides
AU482276B2 (en) Spiro-cyclopropanes
AU482530B2 (en) Benzocycloheptathiophenes
CA1023765A (en) Tertiary-alkylamino-lower acyl-xylidides
AU482866B2 (en) Unsymmetrically-substituted-s-triazines
AU484993B2 (en) Polyhydroxyphenylchromanones
AU485552B2 (en) 2-acyl-4-oxo-pyrazino-isoquinolines
AU486644B2 (en) Fusebox